RecruitingNCT04481321

Clinical and Molecular Study of Endometriosis and Adenomyosis

ENDOCHAP Monocentric Cohort: Clinical and Molecular Study of Endometriosis and Adenomyosis

Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

5,300 participants

Start Date

May 1, 2006

Study Type

OBSERVATIONAL

Conditions

Endometriosis Adenomyosis

Summary

The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 42 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biological/Vaccine for people with adenomyosis and endometriosis. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 42 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.